26 Oct 2020 08:54
Bayer to buy US-based Asklepios Bio for up to $4bn
(Sharecast News) - Germany's Bayer has agreed to buy US biopharmaceutical firm Asklepios BioPharmaceutical for up to $4bn.
Read more(Sharecast News) - Germany's Bayer has agreed to buy US biopharmaceutical firm Asklepios BioPharmaceutical for up to $4bn.
Read more(Sharecast News) - Stocks in Europe are coming of their lows of the session despite the European Commission downgraded growth forecasts and the still worrisome headlines around the coronavirus pandemic which were continuing to roll in.
Read moreLONDON (Alliance News) - Sensyne Health PLC and the life sciences company Bayer AG on Tuesday said they will work together on the development of a UK linked patient data capability.Under as
Read more